Clinical Trial Update: Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating azacitidine to restore thyroid function in patients with persistent or metastatic thyroid cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: Lucille P. Markey Cancer Center at University of Kentucky | Conditions: Head and Neck Cancer | Phase 1 | Status: COMPLETED